Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy
NCT00041795
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Nervous System Diseases
Chemotherapy-Induced Peripheral Neuropathy
Interventions
DRUG:
leteprinim potassium (Neotrofin)
Sponsor
NeoTherapeutics